Cite
HARVARD Citation
Probert, C. et al. (2018). Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis). BMJ open gastroenterology. 5 (1), p. . [Online].